Surgery or endotherapy for high-grade dysplasia/early adenocarcinoma in Barrett's oesophagus?

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 10, 2002, Pages 1049-1051

  Todd, John A ^a   De Caestecker, John ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Barrett's oesophagus; Dysplasia; Endoscopic therapy; Intramucosal cancer

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER MORTALITY; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DYSPLASIA; EARLY CANCER; ENDOSCOPIC THERAPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FOLLOW UP; HUMAN; MORBIDITY; PRIORITY JOURNAL; RISK FACTOR; SAFETY; SHORT SURVEY; ULTRASOUND;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; HUMANS; PRECANCEROUS CONDITIONS;

EID: 0036795902     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200210000-00002     Document Type: Short Survey

References (15)

1. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29:645-654.
2. Hamilton SR, Smith RR, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988; 19:942-948.
3. Williamson WA, Ellis FH Jr, Gibb SP, Shahian DM, Aretz HT, Heatley GJ, et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151:2212-2216.
4. Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993; 72:1155-1158.
5. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130:883-890.
6. Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33:1155-1158.
7. Menke-Pluymers MB, Schoute NW, Mulder AH, Hop WC, van Blankenstein M, Tilanus HW. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 1992; 33:1454-1458.
8. Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Early adenocarcinoma in Barrett's oesophagus. Br J Surg 1997; 84:1470-1473.
9. Van Sandick JW, van Lanschot JJ, Kuiken BW, Tytgat GN, Offerhaus GJ, Obertop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998; 43:216-222.
10. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120:1607-1619.
11. Gossner L, May A, Stolte M, Seitz G, Hahn EG, Ell C. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 1999; 49:8-12.
12. Barr H, Shepherd NA, Dix A, Roberts DJ, Tan WC, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996; 348:584-585.
13. Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000; 118:670-677.
14. May A, Gossner L, Pech O, Fritz A, Günter E, Mayer G, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and long-term results of a new treatment approach. Eur J Gastroenterol Hepatol 2002; 14:1085-1091.
15. Van Laethem JL, Cremer M, Peny MO, Delhaye M, Deviere J. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid-term results. Gut 1998; 43:747-751.